333 related articles for article (PubMed ID: 19248585)
1. [siRNA targeting telomerase--effective tool in anti-cancer therapy?].
Rubiś B; Półrolniczak A; Rybczyńska M
Postepy Biochem; 2008; 54(4):384-92. PubMed ID: 19248585
[TBL] [Abstract][Full Text] [Related]
2. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
3. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
de Souza Nascimento P; Alves G; Fiedler W
Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
[TBL] [Abstract][Full Text] [Related]
4. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
5. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
7. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
8. [The anti-cancer effect of siRNA targeting human telomerase reverse transcriptase in SMMC-7721 cells].
Zheng SJ; Xia Y; Ren H; Zhong S; Yang Y; Tao P; Wang SQ
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):530-3. PubMed ID: 15387903
[TBL] [Abstract][Full Text] [Related]
9. [Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line].
Cheng W; Su Y; Ma HQ; Wei ZF; Gao JP; Zhang ZY; Ge JP; Jing KZ; Xu F
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2847-52. PubMed ID: 20137667
[TBL] [Abstract][Full Text] [Related]
10. [Construction of adenovirus expressing siRNA against hTR and its anti-tumor activity in vitro].
Li Y; Xiao LY; Yao G; Li H; Yang ZW; Li WY; Jiang ZH; Li MY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):570-3. PubMed ID: 18538086
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of telomerase activity in human promyelocytic cell line using RNA interference.
Miri-Moghaddam E; Deezagi A; Soheili ZS
Ann Hematol; 2009 Dec; 88(12):1169-76. PubMed ID: 19415276
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors.
Chen SM; Tao ZZ; Hua QQ; Xiao BK; Xu Y; Wang Y; Deng YQ
Cancer Invest; 2007 Dec; 25(8):691-8. PubMed ID: 18058464
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity.
Qian X; Cheng J; Chen A; Wang Y; Tao Y; Cao J; Feng Z
Oncol Rep; 2008 Feb; 19(2):575-81. PubMed ID: 18202810
[TBL] [Abstract][Full Text] [Related]
15. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
Kelland L
Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
[TBL] [Abstract][Full Text] [Related]
16. Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells.
Wang Y; Duan HG; Chen SM; Xiao BK; Cheng J; Tao ZZ
J Laryngol Otol; 2007 May; 121(5):476-82. PubMed ID: 17156515
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
18. Multiple pathways for the regulation of telomerase activity.
Holt SE; Wright WE; Shay JW
Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
[TBL] [Abstract][Full Text] [Related]
20. Telomerase as a therapeutic target for malignant gliomas.
Komata T; Kanzawa T; Kondo Y; Kondo S
Oncogene; 2002 Jan; 21(4):656-63. PubMed ID: 11850793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]